Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harrigan

Showing results (461-470 of 1,264) with videos related to

Pageof 127
Sort By:
The Journal of Emergency Medicine|May 25, 2012
Alternative treatments of pneumothoraxZachary D Repanshek, Jacob W Ufberg, Gary M Vilke, et al.
Pharmacotherapy|January 27, 2010
Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorderJeffrey J Miceli, Thomas G Tensfeldt, Thomas Shiovitz, et al.
BMJ (Clinical Research Ed.)|July 23, 1999
Identifying appropriate tasks for the preregistration year: modified Delphi techniqueJ Stewart, C O'Halloran, P Harrigan, et al.
Scientific Reports|November 13, 2019
Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methodsKimia Kamelian, Vincent Montoya, Andrea Olmstead, et al.
Hawaii Journal of Public Health|July 1, 2016
Body Ideals and Body Dissatisfaction Among a Community Sample of Ethnically Diverse Adolescents on Kauai, HawaiiTiffany K Niide, James Davis, Alice M Tse, et al.
The Journal of Clinical Psychiatry|March 10, 2001
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patientsM D Lesem, J M Zajecka, R H Swift, et al.
Psychopharmacology|June 13, 2001
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trialD G Daniel, S G Potkin, K R Reeves, et al.
Biochimica Et Biophysica Acta|July 4, 1993
Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradientsP R Harrigan, K F Wong, T E Redelmeier, et al.
Journal of the International AIDS Society|August 9, 2016
Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settingsViviane D Lima, Mark Hull, David McVea, et al.
Cochlear Implants International|June 4, 2015
Cochlear implantation in children with complex needs: the perceptions of professionals at cochlear implant centresSue Archbold, Sheetal Athalye, Imran Mulla, et al.
Pageof 127

Showing results (461-470 of 1,264) with videos related to

Sort By:
Pageof 127
The Journal of Emergency Medicine|May 25, 2012
Alternative treatments of pneumothoraxZachary D Repanshek, Jacob W Ufberg, Gary M Vilke, et al.
Pharmacotherapy|January 27, 2010
Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorderJeffrey J Miceli, Thomas G Tensfeldt, Thomas Shiovitz, et al.
BMJ (Clinical Research Ed.)|July 23, 1999
Identifying appropriate tasks for the preregistration year: modified Delphi techniqueJ Stewart, C O'Halloran, P Harrigan, et al.
Scientific Reports|November 13, 2019
Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methodsKimia Kamelian, Vincent Montoya, Andrea Olmstead, et al.
Hawaii Journal of Public Health|July 1, 2016
Body Ideals and Body Dissatisfaction Among a Community Sample of Ethnically Diverse Adolescents on Kauai, HawaiiTiffany K Niide, James Davis, Alice M Tse, et al.
The Journal of Clinical Psychiatry|March 10, 2001
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patientsM D Lesem, J M Zajecka, R H Swift, et al.
Psychopharmacology|June 13, 2001
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trialD G Daniel, S G Potkin, K R Reeves, et al.
Biochimica Et Biophysica Acta|July 4, 1993
Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradientsP R Harrigan, K F Wong, T E Redelmeier, et al.
Journal of the International AIDS Society|August 9, 2016
Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settingsViviane D Lima, Mark Hull, David McVea, et al.
Cochlear Implants International|June 4, 2015
Cochlear implantation in children with complex needs: the perceptions of professionals at cochlear implant centresSue Archbold, Sheetal Athalye, Imran Mulla, et al.
Pageof 127